These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications]. Plouin PF Therapie; 1984; 39(4):379-90. PubMed ID: 6148791 [No Abstract] [Full Text] [Related]
10. Use of beta-adrenergic receptor blocking drugs in psychiatry. Whitlock FA; Price J Drugs; 1974; 8(2):109-24. PubMed ID: 4154835 [No Abstract] [Full Text] [Related]
11. Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats. Brynne L; Paalzow LK; Karlsson MO J Pharmacol Exp Ther; 1999 Aug; 290(2):664-71. PubMed ID: 10411576 [TBL] [Abstract][Full Text] [Related]
12. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular drug withdrawal syndromes. A potential problem with calcium antagonists? Raftery EB Drugs; 1984 Nov; 28(5):371-4. PubMed ID: 6150842 [No Abstract] [Full Text] [Related]
14. The effect of propranolol on cognitive flexibility and memory in acute cocaine withdrawal. Kelley BJ; Yeager KR; Pepper TH; Bornstein RA; Beversdorf DQ Neurocase; 2007 Oct; 13(5):320-7. PubMed ID: 18781429 [TBL] [Abstract][Full Text] [Related]
15. Alpha- and beta-receptor blocking drugs in the treatment of hypertension. Ram CV; Kaplan NM Curr Probl Cardiol; 1979 Jan; 3(10):1-53. PubMed ID: 40755 [TBL] [Abstract][Full Text] [Related]
16. [Withdrawal effects following interruption of antihypertensive drugs. II. Coronary rebound phenomenon with antihypertensive drugs used in coronary heart disease therapy (author's transl)]. Laham E Sem Hop; 1979 Dec 8-15; 55(41-42):1905-8. PubMed ID: 231311 [TBL] [Abstract][Full Text] [Related]
17. [Propranolol protects the myocardium and prevents arterial hypotension in an experimental organ donation model]. Ojeda Rivero R; Cerro Sánchez J; Ordóñez Fernández A; Domínguez Roldán JM; Hernández Fernández A Rev Esp Anestesiol Reanim; 2002 May; 49(5):229-37. PubMed ID: 12216505 [TBL] [Abstract][Full Text] [Related]
18. [Sympathetic-adrenal system in ischemic heart disease before and after obzidan treatment]. Orlov VN; Chigrinova LS Klin Med (Mosk); 1981 Jun; 59(6):74-8. PubMed ID: 6116820 [No Abstract] [Full Text] [Related]
19. [Role of the adrenergic system in atherogenesis and effects of beta-blockers]. Pauletto P; Dal Palù C G Ital Cardiol; 1989 Jun; 19(6):507-22. PubMed ID: 2572503 [No Abstract] [Full Text] [Related]
20. Stopping beta blockers in patients with angina. Rangno RE Ration Drug Ther; 1981 Sep; 15(9):1-4. PubMed ID: 6127751 [No Abstract] [Full Text] [Related] [Next] [New Search]